Clinical Trial Update: Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients [EARLY_Phase 1]

View source ↗

Summary

This is an early Phase 1 clinical trial registry entry evaluating the safety and efficacy of NRG-103 Injection for recurrent glioblastoma, with recruitment ongo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• NRG-103 Injection

Snippet

Sponsor: Zhongnan Hospital | Conditions: Glioblastoma (GBM) | EARLY_Phase 1 | Status: RECRUITING